ArticleMolecular genetics & genomic medicine2025
Unraveling CBS Mutations and Their Clinical Impact in a Chinese Family With Classical Homocystinuria.
Article in Molecular genetics & genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unraveling CBS Mutations and Their Clinical Impact in a Chinese Family With Classical Homocystinuria.Molecular genetics & genomic medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundClassical homocystinuria (HCU), caused by cystathionine beta-synthase (CBS) deficiency, exhibits significant geographic variability in its mutational spectrum. Although over 191 CBS mutations have been reported worldwide, Chinese cases remain rare and lack common hotspot mutations. This study aimed to characterize novel CBS variants in a Chinese family to expand the known mutational spectrum and inform genetic counseling practices. MATERIALS AND
methodsA Chinese Yi family affected by HCU was analyzed. Clinical features, whole-exome sequencing (WES), and metabolic data were collected. Ancestry composition was evaluated using principal component analysis (PCA) and ADMIXTURE analysis. The pathogenicity of CBS variants was assessed through three-dimensional protein modeling, Western blotting, and enzyme activity assays.
resultsThe proband, a 9-year-old girl with lens dislocation and seizures, carried compound heterozygous CBS mutations: c.1006C>T (p.Arg336Cys) and c.1061_1069del (p.Val354_Val356del), both located within the catalytic domain of the CBS protein. Structural and functional analyses demonstrated that the latter variant disrupts CBS expression and enzymatic activity. Her asymptomatic brother also carried the same compound heterozygous variants and exhibited mild hyperhomocysteinemia. Ancestry analysis revealed predominant East Asian ancestry with 5.2% Central African Pygmy admixture.
conclusionThis study identifies the first CBS c.1061_1069del variant and confirms c.1006C>T pathogenicity in China. The findings expand the CBS mutation spectrum, underscore the importance of ethnicity-specific variants, and provide valuable insights for prenatal diagnosis and genetic counseling in Chinese populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.